By Professor Matthew Gwyn Law

Journal articles

Amin J; Law MG, 2007, 'Causes of death in hepatitis B and C: a methodological issue', Lancet, 370, pp. 1033, http://dx.doi.org/10.1016/S0140-6736(07)61473-1

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J, 2007, 'Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?', International Urogynecology Journal and Pelvic Floor Dysfunction, 18, pp. 123 - 128, http://dx.doi.org/10.1007/s00192-006-0165-z

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244024100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nakhaee FH; McDonald AM; Black DA; Law MG, 2007, 'A feasible method for linkage studies avoiding clerical review: linkage of the national HIV/AIDS surveillance databases with the National Death Index in Australia', Australian and New Zealand Journal of Public Health, 31, pp. 308 - 312

Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321

Friis-Moller N; Reiss P; Sabin C; Weber R; d Arminio Monforte A; El-Sadr W; Thiebault R; De Wit S; Kirk O; Fontas E; Law MG; Phillips A; Lundgren JD, 2007, 'Class of antiretroviral drugs and the risk of myocardial infarction.', New England Journal of Medicine, 356, pp. 1723 - 1735

Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, 8, pp. 171 - 180

Byakwaga H; Zhou J; Law MG; Emery S; Mallon PW; Cooper DA, 2007, 'Effect of nucleoside reverse transcriptase inhibitors (NRTIs) on CD4 recovery for individuals on long-term, fully suppressive antiretroviral therapy (ART)', Antiviral Therapy, 12, pp. L61 - L62

Lampe F; Porter K; Kaldor JM; Law MG; Kinloch-De Loes S; Phillips AN, 2007, 'Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study', Antiviral Therapy, 12, pp. 189 - 193

Zhou J; Paton N; Ditangco R; Chen YF; Kamarulzaman A; Kumarasamy N; Lee CK; Li P; Merati T; Phanuphak P; Pujari S; Vibhagool A; Zhang F; Chuah J; Frost K; Cooper DA; Law MG, 2007, 'Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database', HIV Medicine, 8, pp. 8 - 16

Kariminia A; Butler TG; Corben S; Levy MH; Grant L; Kaldor JM; Law MG, 2007, 'Extreme cause-specific mortality in a cohort of adult prisoners ¿ 1988 to 2002: a data-linkage study.', International Journal of Epidemiology, 36, pp. 310 - 316

Kariminia A; Law MG; Butler TG; Corben S; Levy MH; Kaldor JM; Grant L, 2007, 'Factors associated with mortality in a cohort of Australian prisoners', European Journal of Epidemiology, 22, pp. 417 - 428

Haylen B; Krishnan S; Schulz S; Verity L; Law MG; Zhou J; Sutherst J, 2007, 'Has the true prevalence of voiding difficulty in urogynecology patients been underestimated?', International Urogynecology Journal, 18 (1), pp. 53 - 56

Srasuebkul P; Calmy A; Zhou J; Kumarasamy N; Law MG; Lim P, 2007, 'Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).', AIDS Research and Therapy, 4, pp. 18

Vajdic CM; Van Leeuwen MT; McDonald S; Mccredie M; Law MG; Chapman JR; Webster A; Kaldor JM; Grulich AE, 2007, 'Increased incidence of squamous cell carcinoma of eye after kidney transplantation', Journal of the National Cancer Institute, 99, pp. 1340 - 1342, http://dx.doi.org/10.1093/jnci/djm085

Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, 3, pp. 260 - 267

Haylen B; Chetty N; Logan V; Schulz S; Verity L; Law MG; Zhou J, 2007, 'Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?', International Urogynecology Journal, 18 (2), pp. 121 - 122

Amin J; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Law MG; Dore GJ, 2007, 'Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study', Australian and New Zealand Journal of Public Health, 31, pp. 475 - 482

Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, 21, pp. 2445 - 2453

Razali K; Thein H; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M, 2007, 'Modelling the hepatitis C virus epidemic in Australia', Drug and Alcohol Dependence, 91, pp. 228 - 235, http://dx.doi.org/10.1016/j.drugalcdep.2007.05.026

Regan DG; Philp D; Hocking J; Law MG, 2007, 'Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.', Sexual Health, 4, pp. 147 - 163, http://dx.doi.org/10.1071/SH07042

Amin J; Law MG; Micallef JM; Jauncey ME; Van Beek IA; Kaldor JM; Dore GJ, 2007, 'Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users', Epidemiology and Infection, 135, pp. 144 - 150

Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG, 2007, 'Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment', HIV Medicine, 8, pp. 46 - 54

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075

Kariminia A; Law MG; Butler TG; Levy MH; Corben S; Kaldor JM; Grant L, 2007, 'Suicide risk among recently released prisoners in New South Wales, Australia', Medical Journal of Australia, 187, pp. 387 - 390

Winston A; Mallon PW; Satchell C; MacRae K; Williams KM; Schutz M; Law MG; Cooper DA; Emery S, 2007, 'The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation', Clinical Infectious Diseases, 44, pp. 1475 - 1483

Amin J; Law MG; Dore G, 2006, 'Mortality in patients with hepatitis B or hepatitis C - Authors' reply', Lancet, 368, pp. 1767, http://dx.doi.org/10.1016/S0140-6736(06)69729-8

Habib RR; Abdallah SM; Law M; Kaldor J, 2006, 'Response from the authors: [5]', Australian and New Zealand Journal of Public Health, 30, pp. 189, http://dx.doi.org/10.1111/j.1467-842X.2006.tb00118.x

Hales GP; Birch C; Crowe S; Workman C; Hoy JF; Kelleher AD; Lincoln D; Lincoln D; Law MG; Emery S, 2006, 'A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: The CREST study.', PLoS Clinical Trials, 1, pp. e18

Habib R; Abdallah S; Law MG; Kaldor JM, 2006, 'Cancer incidence among Australian nuclear industry workers', Journal of Occupational Health, 48, pp. 358 - 365

Vajdic CM; McDonald S; Mccredie M; Van Leeuwen MT; Stewart JS; Law MG; Chapman JR; Webster A; Kaldor JM; Grulich AE, 2006, 'Cancer incidence before and after kidney transplantation', JAMA, 296, pp. 2823 - 2831, http://dx.doi.org/10.1001/jama.296.23.2823

Amin J; Dore GJ; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Law MG, 2006, 'Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study', Journal of Hepatology, 45, pp. 197 - 203

Law MG, 2006, 'Cardiovascular complications of HIV: an overview of risk and a novel approach to prevention - the HIV polypill study', Current opinion in HIV & AIDS, 1, pp. 482 - 487

Amin J; Law MG; Bartlett M; Kaldor JM; Dore GJ, 2006, 'Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study', Lancet, 368, pp. 938 - 945

Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24

Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, 11, pp. L12 - L12

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85

Law MG; Puls R; Cheng A; Cooper DA; Carr AD, 2006, 'Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults', Antiviral Therapy, 11, pp. 179 - 186

Weber R; Sabin C; Friis-Moller N; Reiss P; El-Sadr W; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; d Arminio Monforte A; Rickenbach M; Ledergerber B; Phillips AN; Lundgren JD, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus. 2006;166:1632-1641.', Archives of Internal Medicine, 166, pp. 1632 - 1641

Brown DA; Stephan C; Ward RL; Law MG; Hunter M; Bauskin AR; Amin J; Jung K; Diamandis E; Hampton GM; Russell PJ; Giles GG; Breit SN, 2006, 'Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis', Clinical Cancer Research, 12, pp. 89 - 96

Law MG; Degenhardt LJ; McKetin R, 2006, 'Methods estimating the prevalence of problem drug use', International Journal of Drug Policy, 17, pp. 154 - 158

Habib R; Abdallah S; Law MG; Kaldor JM, 2006, 'Mortality rates among nuclear industry workers at Lucas Heights Science and Technology Centre - Respond', Australian and New Zealand Journal of Public Health, 30, pp. 189 - 189

Petoumenos K; Law MG, 2006, 'Risk factors and causes of death in the Australian HIV Observational Database. Sex Health', Sexual Health, 3, pp. 103 - 112

Mocroft A; Neaton JD; Bebchuk JD; Staszewski S; Antunes F; Knysz B; Law MG; Phillips AN; Lundgren JD, 2006, 'The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era', CLINICAL TRIALS, 3, pp. 119 - 132

Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202

Law MG; Friis-Moller N; El-Sadr W; Weber RO; Reiss P; Monforte A; Thiebaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin C; Phillips AN; Lundgren JD, 2006, 'The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D : A : D Study', HIV Medicine, 7, pp. 218 - 230

Thiébaut R; El-Sadr WM; Friis-Møller N; Rickenbach M; Reiss P; Monforte ADA; Morfeldt L; Fontas E; Kirk O; De Wit S; Calvo G; Law MG; Dabis F; Sabin CA; Lundgren JD, 2005, 'Erratum: Hypertension in HIV-infected patients (Antiviral Therapy (2005) 10 (811-823))', Antiviral Therapy, 10, pp. 969

Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163

Back to profile page